microfluidics_market

New York, NY, February 25th, 2019, (PRWirePro) – The Microfluidic Market is on a high growth rate attributing to its various factors such as increase in infectious diseases, need for faster and accurate results at a low cost and increased funding in the healthcare department. However rising cost for implantation and the stringent regulatory process to adapt the new technology hinder the growth rate for micro fluidics to a certain extent.

Market Industry Reports (MIR) has published a new report titled “Microfluidics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global microfluidics market is estimated to be around US$ 4.0 Bn in 2017. It is anticipated to grow at a double digit CAGR from 2019 to 2030.

The Study On key vendors in this Global Microfluidics Market includes are Agilent Technologies, Danaher, Thermo Fisher Scientific, Becton, Dickinson and Company, PerkinElmer, Qiagen, Abbott Laboratories, Fluidigm Corporation, Illumina, Inc., and F. Hoffmann-La Roche AG, among others.

Download free PDF sample of the report from the official link- https://www.marketindustryreports.com/pdf/15

 

Global Microfluidics Market is expected to strongly dominate the global economy with a substantial growth rate in upcoming years.

The continual increase in the number of infectious diseases worldwide has presented a bright prospect for the growth of global microfluidics market. Other factors such increasing healthcare funding coupled with adoption of new technologies are anticipated to contribute substantially to the growth of the global microfluidics market between 2019 and 2030.

Increasing Incidences of Infectious Diseases
According to World Health Organization (WHO) Infectious diseases are one of the major causes of death across the world. It is estimated that the prevalence of infectious disease in Russia is one of the highest in world, followed by Brazil and US.  According to Center for Disease Control (CDC), the total number of individuals suffering from hepatitis A in 2011 was approximately 2,700. Similarly, the number of individuals suffering from chronic hepatitis B was estimated to be between 2.5 to 3.9 million. Growing incidences of such infectious diseases has presented a lucrative growth prospect for the microfluidics market, as this technique is widely used for detection of such conditions.

This report provides in depth study of “Microfluidics Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Microfluidics Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Stringent Regulatory Scenario to Restrain the Market
The presence of stringent regulatory processes is one of the major factors affecting the growth of the membrane chromatography market. Similarly complex regulatory approval scenario is anticipated to restrain the extensive growth of the market during the forecast period.

Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Microfluidics Market by Type (Chips, Sensors, Micro-Pumps, Micro-Needles), Material (Glass, Silicon, Polymer), Application (In-Vitro Diagnostics, Drug Delivery, Laboratory Testing, Pharmaceutical & Life Science) – Global Analysis & Forecast 2019-2030  in detail along with the table of contents: https://www.marketindustryreports.com/15/microfluidics-market

Rapid Growth of the Asia Pacific Market
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Rising healthcare expenditure in developing countries and increasing burden of infectious diseases is anticipated to present a lucrative growth scenario for the microfluidics market in this region. Furthermore, improving healthcare facilities, coupled with growing awareness among the population in the region is expected to present an attractive growth prospect for the market in the coming years.

Key Point of Table of Contents: 
11     COMPANY PROFILES
(Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*

11.1   Thermo Fisher Scientific
11.2   Agilent Technologies, Inc.
11.3   Danaher
11.4   Becton, Dickinson and Company
11.5   PerkinElmer
11.6   Qiagen
11.7   F. Hoffmann-La Roche AG
11.8   Abbott Laboratories
11.9   Illumina, Inc.
11.10     Fluidigm Corporation
Continue…

Report holds answers to important questions 

1.What will the local and international competition for vendors operating in the Microfluidics Market look like during the forecast period, 2019 to 2030?
2.What impact will innovative technology and product substitutes have on the use of a service and product?
3.What are the trade barriers in the Microfluidics Market?
4.What are the important catalysts that will shape the preference of the customers during the forecast period, 2019 to 2030?
5.What will be the expected ROI (return on investment)? How much profit will the Microfluidics Market players make?
6.Which distribution trends and developments will continue to dominate the Microfluidics Market in the coming years?

Interested in owning the report right away? Buy your original copy from the official link below@ https://www.marketindustryreports.com/checkout/15

502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001,Maharashtra, India
Email: sales@marketindustryreports.com
Phone: + 91 8956 767 535
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Facebook

Categories: NewsNewsroom